首页>
外国专利>
Antibrucellosis vaccine - from cultures contg brucella and brucella antiserum
Antibrucellosis vaccine - from cultures contg brucella and brucella antiserum
展开▼
机译:抗布鲁氏菌病疫苗-来源于布鲁氏菌和布鲁氏菌抗血清的培养物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Microorganisms, esp. Brucells, are cultured serially in a medium contg. the corresponding anti-serum in order to modify the pheotype but not the genotype. The product is deactivated by formaldehyde and may be treated with sodium lauryl sulphate to give a product which does not contain agglutinins which interfere with the diagnosis of the particular disease. In an example highly pathogenic Brucella Melitensis was isolated and cultured 10-30 times on tryptose-agar contg. 10% anti serum titrating at 2000 U/ml. This strain was lyophilised and was used to prepare vaccine on a prodn. scale. From this stock inoculum 2-10 subcultures were carried out, generally in a liq. medium contg. anti-specific serum.
展开▼
机译:微生物,特别是Brucells在连续的培养基中连续培养。相应的抗血清以修饰表型而不是基因型。该产物被甲醛减活,可以用月桂基硫酸钠处理,得到的产物不含凝集素,这些凝集素干扰了特定疾病的诊断。在一个实例中,分离出高致病性的布鲁氏布鲁氏菌,并在胰蛋白琼脂琼脂上培养10-30次。 10%抗血清滴定于2000 U / ml。将该菌株冻干并用于制备产品。规模。从这种原种接种物中,通常在液中进行2-10次亚培养。中续抗特异性血清。
展开▼